Details for New Drug Application (NDA): 022272
✉ Email this page to a colleague
The generic ingredient in OXYCONTIN is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
Summary for 022272
| Tradename: | OXYCONTIN |
| Applicant: | Purdue Pharma Lp |
| Ingredient: | oxycodone hydrochloride |
| Patents: | 20 |
Pharmacology for NDA: 022272
| Mechanism of Action | Full Opioid Agonists |
Suppliers and Packaging for NDA: 022272
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272 | NDA | Purdue Pharma LP | 59011-410 | 59011-410-10 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59011-410-10) |
| OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272 | NDA | Purdue Pharma LP | 59011-410 | 59011-410-20 | 2 BLISTER PACK in 1 CARTON (59011-410-20) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
| Approval Date: | Apr 5, 2010 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Mar 30, 2025 | Product Flag? | Substance Flag? | Y | Delist Request? | ||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Mar 30, 2025 | Product Flag? | Substance Flag? | Y | Delist Request? | ||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Aug 24, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Expired US Patents for NDA 022272
Complete Access Available with Subscription
